The University of Southampton
×
Filter your search:
University of Southampton Institutional Repository

Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial

Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial
Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial
Patients with cognitive impairment (CI) often do not receive secondary fracture prevention. Use of zoledronic acid led to a similar reduction in re-fracture risk but the survival benefit was limited to those without CI.
We tested whether the effects of zoledronic acid (Zol) on re-fracture and mortality differed in patients presenting with a hip fracture by cognitive status.
0937-941X
77-83
Prieto-Alhambra, D.
19a5643f-5969-4c0e-b6a9-863fb9e9d1c7
Judge, A.
c6a83964-1d7c-4aa8-b2bf-9c264d1e487d
Arden, N.K.
23af958d-835c-4d79-be54-4bbe4c68077f
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Lyles, K.W.
e977293d-eb58-4874-91cc-5783f205702f
Javaid, M.K.
51d3310b-032e-4c15-83ac-b878bce090f3
Prieto-Alhambra, D.
19a5643f-5969-4c0e-b6a9-863fb9e9d1c7
Judge, A.
c6a83964-1d7c-4aa8-b2bf-9c264d1e487d
Arden, N.K.
23af958d-835c-4d79-be54-4bbe4c68077f
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Lyles, K.W.
e977293d-eb58-4874-91cc-5783f205702f
Javaid, M.K.
51d3310b-032e-4c15-83ac-b878bce090f3

Prieto-Alhambra, D., Judge, A., Arden, N.K., Cooper, C., Lyles, K.W. and Javaid, M.K. (2014) Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial. Osteoporosis International, 25 (1), 77-83. (doi:10.1007/s00198-013-2420-8). (PMID:23812596)

Record type: Article

Abstract

Patients with cognitive impairment (CI) often do not receive secondary fracture prevention. Use of zoledronic acid led to a similar reduction in re-fracture risk but the survival benefit was limited to those without CI.
We tested whether the effects of zoledronic acid (Zol) on re-fracture and mortality differed in patients presenting with a hip fracture by cognitive status.

This record has no associated files available for download.

More information

Published date: January 2014
Organisations: Faculty of Medicine

Identifiers

Local EPrints ID: 362048
URI: http://eprints.soton.ac.uk/id/eprint/362048
DOI: doi:10.1007/s00198-013-2420-8
ISSN: 0937-941X
PURE UUID: 5c6bdd93-0089-47e9-8c94-731d2defe26f
ORCID for C. Cooper: ORCID iD orcid.org/0000-0003-3510-0709

Catalogue record

Date deposited: 12 Feb 2014 16:14
Last modified: 18 Mar 2024 02:45

Export record

Altmetrics

Contributors

Author: D. Prieto-Alhambra
Author: A. Judge
Author: N.K. Arden
Author: C. Cooper ORCID iD
Author: K.W. Lyles
Author: M.K. Javaid

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information
Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×